Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 10035804 Spirodiamine derivatives as aldosterone synthase inhibitors

Overview Structured Data Issues Contributors Activity

Is a

Patent attributes

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

Patent Inventor Names

Yongfu Liu0

Dongbo Li0

Alexander Mayweg0

Benoit Hornsperger0

Bernd Kuhn0

Hans Peter Maerki0

Jianhua Yu0

Johannes Aebi0

...

Date of Patent

July 31, 2018

Patent Application Number

15479701

Date Filed

April 5, 2017

Patent Citations Received

US Patent 11639346 Quinazoline derivatives as modulators of mutant KRAS, HRAS or NRAS

0

US Patent 11274093 Fused bicyclic benzoheteroaromatic compounds and methods of use thereof

0

US Patent 11279689 1-(3-(6-(3-hydroxynaphthalen-1-yl)benzofuran-2-yl)azetidin-1 yl)prop-2-en-1-one derivatives and similar compounds as KRAS G12C modulators for treating cancer

US Patent 12134620 Heterocyclic spiro compounds and methods of use thereof for the treatment of cancer

0

US Patent 11358959 Benzothiophene and benzothiazole compounds and methods of use thereof

US Patent 11377441 Covalent inhibitors of KRAS

US Patent 11878985 Substituted quinazolines as inhibitors of KRAS G12C

0

US Patent 11059819 Fused hetero-hetero bicyclic compounds and methods of use thereof

0

Patent Primary Examiner

Alexander R Pagano

Patent abstract

The invention provides novel compounds having the general formula (I)

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 10035804 Spirodiamine derivatives as aldosterone synthase inhibitors

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool